SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Clinical trials for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 explained in plain language.
Never miss a new study
Get alerted when new SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 trials appear
Sign up with your email to follow new studies for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New COVID-19 vaccine trial for kids aims to boost protection
⭐️ VACCINE ⭐️ OngoingThis study tests an updated COVID-19 vaccine in healthy children aged 6 months to 12 years. The goal is to see if the vaccine is safe and triggers a strong immune response. Children who have or haven't had a COVID-19 vaccine before can join. The study will track side effects and …
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Phase: PHASE3 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:38 UTC
-
COVID lung scarring: who gets it and why?
Knowledge-focused OngoingThis study looks at how often severe COVID-19 leads to lung scarring (pulmonary fibrosis) and what factors increase that risk. Researchers will follow 200 intensive care patients to see if scarring affects survival and recovery. The goal is to better understand and predict this c…
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC